36 Results for "

NOP receptor

" in MedChemExpress (MCE) Product Catalog:
Products (36)

36 Results for "NOP receptor" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-114452
CAS No.: 1307245-86-8
Purity:  99.91%
Synonyms: BTRX-246040
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

LY2940094 (BTRX-246040) is a potent, selective and orally available nociceptin receptor (NOP receptor) antagonist with high affinity (Ki=0.105 nM) and antagonist potency (Kb=0.166 nM). LY2940094 reduces ethanol self-administration in animal models .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-114452A
CAS No.: 1307245-87-9
Synonyms: BTRX-246040 tartrate
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

LY2940094 (BTRX-246040) tartrate is a potent, brain penetrant, selective and orally available N/OFQ peptide (NOP) receptor antagonist with high affinity (Ki=0.105 nM) and antagonist potency (Kb=0.166 nM). LY2940094 tartrate reduces Ethanol self-administration and Ethanol seeking in animal models .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-12844
CAS No.: 280783-56-4
Purity:  99.82%
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

Ro 64-6198 is a potent, selective, nonpeptide, high-affinity, high cellular permeability and brain penetration N/OFQ receptor (NOP) agonist with an EC50 value of 25.6 nM. Ro 64-6198 is at least 100 times more selective for the NOP receptor over the classic opioid receptors. Ro 64-6198 can be used for stress and anxiety, addiction, neuropathic pain, cough, and anorexia .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-13222
CAS No.: 1401463-54-4
Purity:  99.68%
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease Cancer

BAN ORL 24 is a nociceptin/orphanin FQ (N/OFQ) peptide receptor (NOP) antagonist. BAN ORL 24 has antagonistic effect for nociceptin (NOP) receptor with KI value of 0.24 nM in CHO cell. BAN ORL 24 can be used for the research of cancer and analgesic .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-13101
CAS No.: 1108147-88-1
Purity:  99.98%
MCOPPB trihydrochloride is a NOP/ORL1 G protein-coupled receptor agonist and autophagy inhibitor that can cross the blood-brain barrier. MCOPPB trihydrochloride clears senescent cells, regulates locomotion, lipid storage and immune responses, and inhibits fibrosis and angiogenesis. MCOPPB trihydrochloride blocks autophagic flux, induces changes in locomotion and lipid storage, and activates the stress-responsive immune transcription network, thereby improving post-infarction cardiac function and exerting anxiolytic effects. MCOPPB trihydrochloride can be applied to research fields such as aging-related diseases and ischemic heart failure .
loading...
    loading...
Cat. No.: HY-128865
CAS No.: 2059904-66-2
Purity:  98.32%
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

BPR1M97 is a dual-acting mu opioid receptor (MOP) and nociceptin-orphanin FQ peptide (NOP) receptor agonist with Ki values of 1.8 and 4.2 nM, respectively. BPR1M97 shows high potency and blood-brain barrier penetration, and produces potent antinociceptive effects .
loading...
    loading...
Cat. No.: HY-P1302
CAS No.: 178249-41-7
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

Orphanin FQ(1-11), a orphanin FQ or nociceptin (OFQ/N) fragment, is a potent NOP receptor (ORL-1; OP4) agonist, with a Ki of 55 nM. Orphanin FQ(1-11) has no affinity for μ, δ, κ1 and κ3 receptors (Ki>1000 nM). Orphanin FQ(1-11) is analgesic in CD-1 mice .
loading...
    loading...
Cat. No.: HY-107722
CAS No.: 322473-89-2
Purity:  99.00%
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

SCH 221510 is a potent, orally active and selective NOP (nociceptin opioid receptor) agonist, with an EC50 of 12 nM and Ki of 0.3 nM. SCH 221510 shows an anxiolytic-like effect .
loading...
    loading...
Cat. No.: HY-107743
CAS No.: 119630-94-3
Purity:  98.36%
Synonyms: NalBzoH
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

Naloxone benzoylhydrazone (NalBzoH) is a mixed agonist/antagonist. Naloxone benzoylhydrazone is a prototypic κ3-opioid receptor agonist, and a partial agonist at the cloned μ and δ opioid receptors, and an antagonist at opioid-like NOP receptors. Naloxone benzoylhydrazone has potently analgesia effect .
loading...
    loading...
Cat. No.: HY-P1299A
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

UFP-101 TFA is a potent, selective, and competitive antagonist of the N/OFQ peptide (NOP) receptor, with a pKi of 10.24. UFP-101 TFA displays >3000-fold selectivity over δ, μ and κ opioid receptors. UFP-101 TFA shows antidepressant-like effect .
loading...
    loading...
Cat. No.: HY-P1302A
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

Orphanin FQ(1-11) TFA, a orphanin FQ or nociceptin (OFQ/N) fragment, is a potent NOP receptor (ORL-1; OP4) agonist, with a Ki of 55 nM. Orphanin FQ(1-11) TFA has no affinity for μ, δ, κ1 and κ3 receptors (Ki>1000 nM). Orphanin FQ(1-11) TFA is analgesic in CD-1 mice .
loading...
    loading...
Cat. No.: HY-156972
CAS No.: 2099681-43-1
Target:  

Opioid Receptor

Research Areas:  

Metabolic Disease

NOP agonist-1(compound 4) is a nociceptin opioid receptor (NOP) partial agonist. NOP agonist-1attenuate parkinsonian disabilities in 6-OHDA hemilesioned rats .
loading...
    loading...
Cat. No.: HY-122681
CAS No.: 857262-16-9
Synonyms: SR-16435 free base
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

SR-16434 is a nociceptin/orphanin FQ (NOP)/μ-opioid receptor partial agonist, with high binding affinity (NOP receptor Ki=7.49; μ-Opioid receptor Ki=2.70). SR-16434 can relieve pain .
loading...
    loading...
Cat. No.: HY-P1319
CAS No.: 178249-42-8
Target:  

Opioid Receptor

Research Areas:  

Inflammation/Immunology

Nociceptin (1-7) is the N-terminal bioactive fragment of nociceptin (HY-P0183). Nociceptin (1-7) is a potent ORL1 (NOP) receptor agonist with antinociceptive activity. Nociceptin (1-7) combines with nociceptin reduces hyperalgesia in vivo .
loading...
    loading...
Cat. No.: HY-10886
CAS No.: 1028969-49-4
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

MCOPPB is an orally active and selective agonist of Nociceptin/Orphanin FQ–Receptor. MCOPPB inhibits signaling through the NOP receptor in the mouse brain. MCOPPB is used in anxiety disorders research .
loading...
    loading...
Cat. No.: HY-P1299
CAS No.: 849024-68-6
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

UFP-101 is a potent, selective, and competitive antagonist of the NOP receptor, with a pKi of 10.24. UFP-101 displays >3000-fold selectivity over δ, μ and κ opioid receptors. UFP-101 shows antidepressant-like effect .
loading...
    loading...
Cat. No.: HY-106732
CAS No.: 1657028-64-2
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

AT-076 is an opioid pan antagonist at nociception, kappa, mu, and delta opioid receptors, with Ki values of 1.75 nM (NOP), 1.67 nM (MOP), 1.14 nM (KOP) and 19.6 nM (DOP), respectively .
loading...
    loading...
Cat. No.: HY-P1316A
CAS No.: 408305-09-9
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

Ac-RYYRWK-NH2 is a potent and selective partial agonist for the nociceptin receptor (NOP), [ 3H]Ac-RYYRWK-NH2 binds to rat cortical membranes ORL1 with a Kd of 0.071 nM, but has no affinity for μ-, κ- or δ-opioid receptors .
loading...
    loading...
Cat. No.: HY-11052A
CAS No.: 1216621-00-9
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

Trap-101 hydrochloride is a potent, selective and competitive antagonist of NOP receptors over classical opioid receptors. Trap-101 stimulates GTPγ 35S binding to CHOhNOP membranes with pKi values of 8.65, 6.60, 6.14 and <5 for NOP, μ-, κ-, and δ-opioid receptors, respectively. Trap-101 attenuates motor deficits in a rat model of parkinson's disease and can be used for the research of nervous system diseases .
loading...
    loading...
Cat. No.: HY-118987
CAS No.: 2099680-72-3
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

AT-127 is a NOP receptor partial agonist, stimulating NOP/G-protein interaction in a concentration dependent manner .
loading...
    loading...